fropenem has been researched along with Acute Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, S; Fujino, K; Hashimoto, J; Hiyama, Y; Ichihara, K; Masumori, N; Shinagawa, M; Takahashi, S; Uehara, T | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Alefelder, M; Arvis, P; Berg, O; Gehanno, P; Leiberman, A; Martinkenas, JL; Nikolaidis, P; Reimnitz, P; Siegert, R | 1 |
| Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J | 1 |
| Echols, RM; Hadley, JA; Tillotson, GS; Tosiello, R | 1 |
| Arguedas, A; Critchley, IA; Dagan, R; Echols, RM; Janjic, N; Leibovitz, E; Stone, KC; Wang, E | 1 |
1 review(s) available for fropenem and Acute Disease
| Article | Year |
|---|---|
Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Sinusitis; Streptococcus pneumoniae; United States | 2006 |
2 trial(s) available for fropenem and Acute Disease
| Article | Year |
|---|---|
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Female; Humans; Lactams; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Treatment Outcome | 2003 |
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Sinusitis; Time Factors | 2006 |
3 other study(ies) available for fropenem and Acute Disease
| Article | Year |
|---|---|
The efficacy of faropenem for patients with acute cystitis caused by extended spectrum β-lactamase producing Escherichia coli.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cystitis; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult | 2017 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Child; Costa Rica; Ear, Middle; Haemophilus influenzae; Humans; Israel; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media with Effusion; Streptococcus pneumoniae; Streptococcus pyogenes | 2007 |